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gency room. Sixty pts were on mechanical ventilatory support. Passage of
the scope was difficult in 2 pts. Nine developed transient hypoxemia, one
requiring mechanical ventilation.
Findings: 116 pts (82%) had no evidence of aortic trauma on TEE. Aor-
tic disruption was noted in 6 pts (4%). 5 of whom underwent surgery and
survived. In 15 pts the findings were indeterminate. Aortogram in these pts
were negative for trauma. Disruption involving the distal arch was missed in
2 pts. Both died.
Conclusions: (1) TEE may be safely and rapidly performed in pts with BCT
despite a high proportion being critically ill. (2) A low yield of aortic disruption
is obtained when the pre-test probability is low. (3) Early identification of
aortic disruption by TEE and prompt surgical management improves survival.
(4) Correct identification of disruption may be difficult in some cases where
there is inadequate visualization of the aorta. (5) The diagnostic accuracy
in identifying aortic disruption may be improved by the newer multiplanar
TEE imaging modalities and by increasing operator experience with TEE in
BCT pts, making this the procedure of choice in cases of suspected aortic
disruption.
Heterozygous familial hypercholesterolemia (HFH) is strongly associated
with premature atherosclerosis. To assess the degree of thoracic aorta
atherosclerosis (TAA) in patients with HFH with no evident coronary heart
disease, 34 patients (age 41 ± 10 years) were studied by transesophageal
echocardiography(TEE) and compared to 34 age and sex matched controls,
All patients had negative coronary heart disease history and negative stress
test.
TEE detection of normal or mild intimal irregularity were Grade I; increased
echo density of the intima with well-defined atheroma extending <3 mm in
the aortic lumen were Grade II, atheroma >3 mm were Grade III and pro-
truding mobile or pendunculated plaques were Grade IV. Grades II-IV were
considered as TAA. TEE detected atherosclerotic plaques in 13/34 (3B.2%)
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Role of Transesophageal Echocardiography in the
Diagnosis and Management of Traumatic Rupture of
the Aortic Isthmus
Philippe Vignon, Pascal Gueret. Jean-Marc Vedrinne, Philippe Lagrange,
Marie-Paule Boncoeur, Herve Gastinne. Intensive Care Unit & Cardiology. Dupuylren
Hospital, LJmoges, France
A comprehensive description of transesophageal echocardiographic (TEE)
findings associated with traumatic aortic rupture (TAR) is still lacking. To cor-
relate TEE and anatomic findings, a prospective study was conducted in 29
consecutive patients suffering from blunt chest trauma and suspected TAR.
Confirmation of the diagnosis of TAR was obtained by either aortography,
surgery, or necropsy in all patients. TEE studies were performed during the
first day of admission using a monoplane probe. TEE studies and aortograms
were reviewed by independent experienced observers. The diagnosis of sub-
adventitial TAR was made in 9 patients and intimal tears in 2 patients (one
confirmed and one missed by aortography). Subadventitial TAR appeared
as an abnormal thick structure composed of intima and media, and mobile
within the isthmus lumen. Color flow mapping revealed no differences in
blood flow velocity on both sides of the disrupted aortic wall with turbu-
lent flow surrounding the traumatic tear. Symmetric or asymmetric localized
aortic enlargement reflecting the adventitia under tension was also noted.
This type of lesion requires prompt surgical repair. In contrast. intimal aor-
tic tears appeared as very mobile thin appendages of the aortic wall. Color
flow mapping demonstrated a localized mosaic of colors reflecting blood
flow turbulence around the intimal laceration, Aortic diameter remained un-
changed, since the tear was too small and superficial to induce adventitial
distention. Since these lesions appear to regress spontaneously, conserva-
tive management and TEE follow-up was undertaken. TEE failed to diagnose
a two-millimeter long medial aortic rupture with integrity of the adventitia
(demonstrated at necropsy). Aortography must be obtained when the TEE
study is equivocal or when a laceration of the aortic arch and the brachio-
cephalic arteries is suspected.
Conclusions: In this study, transesophageal echocardiographic and
anatomic findings in patients with traumatic aortic rupture were strongly cor-
related. In experienced hands, TEE can be considered as an accurate firstline
imaging technique for the diagnosis and management of traumatic aortic
rupture.
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1753-61 Thoracic Aorta Atherosclerosis in Patients with
Heterozygous Familial Hypercholesterolemia. A
Transesophageal Echocardiographic Study
John Barbetseas, Christos Pitsavos, John Skoumas, Constadina Aggeli,
Maria Apostolidau, Gregory Vyssoulis, Pavlas Toutouzas. Cardiac Department,
University ofAthens, Greece
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Microscopic evaluation of surgical specimens in 6 with IMH of Asc Ao
showed similarfindings to classical AD, Complications of AD, CD and enlarg-
ing aneurysms were evaluated in the 130 pts. TEE showed 100% accuracy
for aortic regurgitation and pericardial ruptures. The sensitivities were 75%,
85% and 11 %, respectively for TEE for pseudoaneurysms (12 pts). hemoth-
orax(20 pts) and hemomediastinum (9 pts), with the specificity for all 100%,
Conclusions Bi and multiplane TEE accurately detected AD and its ma-
jor complications, but thrombosed false lumen, intramural hematomas and
pseudoaneurysms need special attention. TEE was inaccurate in identifying
mediastinal leaks and ruptures.
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Transesophageal Echocardiographic Findings of
Non-traumatic Thoracic Aortic Rupture with or
without Associated Dissection
Kenneth J. Yvorchuk, Randall A, Sochowski, Kwan L. Chan. University of Ottawa
Heart Institute, Ottawa, Canada
Thoracic aortic rupture in the absence of trauma is a rare but life-threatening
condition which requires prompt and accurate diagnosis. Transesophageal
echocardiography (TEE) has become the diagnostic tool of choice in aor-
tic dissection, but its role in the detection of aortic rupture has not been
well defined. To assess the TEE features of non-traumatic aortic rupture we
reviewed 3800 consecutive TEE studies to identify patients diagnosed by
TEE to have aortic rupture and with convincing clinical findings such as early
deaths or surgical confirmation. Ten patients were identified (5 men and 5
women, age 70.3 ± 5.9 years). All presented with chest pain, and 7 had
hypotension. One patient ruptured into the pericardium and 9 into the medi-
astinum. Associated aortic dissection (3 type A and 3 type B) was present in
6. Urgent surgery was performed in 5, 2 of whom survived. All 5 non-surgical
patients died, and autopsy was performed in 3 with confirmation of the di-
agnosis. TEE findings were as follows: indistinct aortic wall in 10, extrinsic
periaortic mass in 10, dilated descending aorta in 10, aortic aneurysm in 6,
and dissection flap in 6. The rupture site was thrombosed in 7, while in the
remaining 3 patients free flowing blood into the mediastinum was detected.
Conclusion: Non-traumatic aortic rupture can occur with or without dissec-
tion. The findings on TEE of an indistinct aortic wall and periaortic hematoma
in an enlarged aorta strongly suggest rupture. Early diagnosis by TEE leading
to corrective surgery may result in a more favourable outcome.
Amar Singh, Steven A. Fein, Vivienne E. Smith, Carroll. Duffy, Suzanne Saletta,
John Fortune. Albany Medical College, Albany. NY
Rupture of the aorta resulting from blunt chest trauma (BCT) is often fatal.
Early diagnosis and surgical treatment improves the chances of survival.
Transesophageal echocardiography (TEE) permits accurate and rapid visu-
alization of the thoracic aorta and is ideal in evaluating such patients. We
performed TEE as the initial diagnostic procedure in 141 patients (pts) with
BCT. 90% had a widened mediastinum on chest x-ray (CXR) as an indica-
tion of possible aortic damage. 92% of studies were performed in the emer-
1753-21 Biplane and Multiplane Transesophageal
Echocardlography in Suspected Acute Aortic
Dissection
Andre Keren, Charles B. Kim, Bob Hu, Irina Eyngorina, Margaret E. Billingham, R.
Scott Mitchell, D. Craig Miller, Richard L. Popp, Ingela Schnittger. Stanford
University. Stanford, CA
Between 1991-1994, 130 pts, (95 men, age 17-88 yrs.) were evaluated by
bi or multiplane transesophageal echocardiography (TEE) because of sus-
pected acute aortic dissection (AD) (112 pts) or acute extension of chronic
dissection (CD) (18 pts), TEE results were compared to diagnoses obtained
by surgery/necropsy (55%) or by at least one additional imaging method.
Results - The accuracy of TEE in AD: AD was present in 49 (type A in 3D,
Type B in 19) of the 112 pts. (44%) and 8 of them had intramural hematoma
IIMH). TEE found AD in 48/49 pts. with, and excluded AD in 78/81 without.
that diagnosis. The 1 pt. with false negative TEE had a 1.5 cm thrombosed
false lumen in the ascending aorta (Asc Ao), Two pts. with Type A AD (1 with
IMH and 1 with thrombosed false lumen in the Asc Ao) were classified as
type B AD. The 3 false positive diagnoses were in 2 pts. with large aneurysms
of the Asc Ao and in 1 in the Desc Ao. The accuracy of TEE for AD was:
230A ABSTRACTS lACC February 1995
HFH patients (8 Grade II, 5 Grade III) vs 3/34 (8.8%) of the controls 13 Grade
II). (p = 0.004). When the patients were divided according to age «40 years
and >40 years) and compared to age and sex matched controls no differ-
ence was detected in the younger ones (7.1 % vs 5.9%, P = NS). while in
the elderly groups, HFH patients had more severe TAA (60% vs 11.8%, p =
0.003). It is concluded that patients with HFH commonly suffer from progres-
sive atherosclerosis, even in the absense of manifest coronary angiopathy.
This can easily be detected and followed-up by TEE.
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1754-1 1 Biatrial Synchronous Pacing: A New Therapeutic
Approach to Prevent Refractory Atrial
Tachyarrhythmias
Claude Daubert, Daniel Gras, Christophe Leclercq, J. Michel Ba'issel,
Frederic Victor, Philippe Mabo. University Hospital, Rennes, France
To test the hypothesis that biatrial synchronous pacing (BASPI may pre-
vent atrial tachyarrhythmia (AT) recurrences in selected cases, we prospec-
tively implanted permanent pacemakers providing BASP in 20 consecutive
patients. Inclusion criteria were the association of (1) multiple (:0:31 recur-
rences of permanent AT without any efficacy of drug therapy (mean = 3.5
drugs/pt). Atrial fibrillation in 12 Pts; atypical Atrial Flutter involving the left
atrium in the reentry circuit in 12 pts; common Atrial Flutter in 3 pts; and Atrial
Tachycardia in 4 Pts (2) major intra- and interatrial conduction block with a
mean interatrial conduction time of 150 ± 40 ms during spontaneous sinus
rhythm (SSR). The pacing system consisted of two atrial leads, one placed
in the high right atrium and the other one into the coronary sinus to sense
and pace the left atrium, both connected via a Y bifurcated connector at the
atrial port of a SSI pacemaker programmed in the AAT or AATR mode (bipo-
lar pacing and sensing configuration) in 5 pts with normal AV conduction,
or of a DOD pacemaker with a special program of "atrial resynchronization"
loaded into the RAM memory in 15 pts. In all pts, BASP provided permanent
atrial resynchronization as well during atrial pacing, as during SSR and after
atrial extrasystoles. During permanent A pacing the mean P wave duration
decreased from 209 ± 38 ms without BASP to 108 ± 13 ms with BAS P (p
< 0.001). After a mean follow-up of 18 months (range: 3-66). 12 pts (60%)
remained totally free from AT recurrences. 4 pts had short episodes of AT
which resolved spontaneously. Only 4 pts (20 %) returned to permanent AT.
There was no significant difference according to the type of AT.
These preliminary results suggest a potential role for BASP to prevent re-
currences of drug refractory AT in selected pts with intra- and interatrial con-
duction block.
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Dual Site Atrial Pacing for the Acute and Chronic
Prevention of Atrial Fibrillation: A Prospective Study
Atul Prakash, Sanjeev Saksena, Michael Hill, Julie Berg, Maria Diaz, Ryszard
B. Krol, Philip Mathew, Irakli Giorgberidze, Nadeem Haque, Rahul Mehra. Eastern
Heart Ins!. Passaic & NJ Med School, Newark, NJ
We evaluated the feasibility of dual site atrial pacing (DAP) at the high RA &
coronary sinus os & its efficacy in the immediate &chronic prevention of atrial
fibrillation (AF) using a prospective crossover study design. 13 patients (pts)
with drug refractory paroxysmal or chronic AF, mean age 68 ± 15 yrs, mean
LV ejection fraction 49 ± 17%, mean LA diameter 37 ± 7 mm with >2 docu-
mented episodes in prior 6 mos, were considered for DAR AF was induced
using 1, 2 or 3 extrastimuli at 2 to 4 RA sites & DAP was tested acutely for
prevention of induced AF. Chronic DAP was instituted using 2 atrial leads &
1 ventricular lead in the DOOR mode. DAP was switched to single site atrial
pacing after 3 mos while remaining in the DOOR mode. Endpoint for fail-
ure with either pacing mode was recurrent AF needing new antiarrhythmic
drugs or D.C. cardioversion. Results: 11 pts had DAP tested acutely. Mean P
wave duration was 120 ± 33 ms & PA interval was 49 ± 22 ms. The effective
refractory period at the coronary sinus os was 225 ± 17 ms & at the high
RA was 238 ± 22 ms (p > 0.2). Acutely, DAP prevented AF in 4 of 11 pts. 8
pts had permanent pacemakers implanted to institute chronic DAR In 4 pts,
DAP had been effective acutely in suppression of inducible AF whereas it
was ineffective in 2 pts & was not tested in 2 pts. Atrial pacing threshold at
the high RA was 0.9 ± 0.2V, at the coronary sinus os was 1.4 ± 0.2V, & with
DAP was 1.5 ± 0.5V (p = 0.01 vs high RA). P wave amplitude at the coronary
sinus os was 2.15 ± 0.85 mV, at the high RA was 2.75 ± 1.1 V, & with DAP
was 2.52 ± IV During followup of 3 to 180 (mean 92) days, all 8 pts during
DAP remained in sinus rhythm despite a decrease in antiarrhythmic drug use
(mean 2.1 ± 1 before DAP vs 0.4 ± 0.5 after DAR p < 0.001). 5 pts did not
require any antiarrhythmic therapy & the remaining 3 were maintained on 1
previously ineffective drug. In 1 of 4 pts switched to single site atrial pacing,
sustained AF recurred requiring cardioversion. Conclusions: (1) DAP is fea-
sible & can be evaluated acutely at electrophysiologic study or chronically
using currently available DOOR pacemakers. (2) Acutely, DAP can suppress
inducible AF in selected pts. (3) Chronically, DAP can preventAF recurrences
during intermediate term followup.
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1754-31 Impact of Atrial Fibrillation on the Risk of Death: The
Framingham Study
Emelia J. Benjamin, Daniel Levy, Ralph B. D'Agostino, Albert J. Belanger, Philip
A. Wolf. Framingham Study, Framingham, MA
Although atrial fibrillation (AF) is known to cause substantial morbidity, it re-
mains unclear to what extent AF promotes mortality, independent of other
associated risk factors (RF) for death. Methods: We examined the contribu-
tion of AF to mortality in the population-based Framingham Study. Stratified
Cox proportional hazards models, with approximately 2 controls per case,
matched on age and sex, were examined with up to 38 years of follow-up.
Subjects were eligible if they were between the ages of 55 and 94 (at the on-
set of AF or control selection). and were free of prevalent AF. The study group
consisted of 777 men with 460 deaths, and 810 women with 477 deaths
during follow-up. The age- and RF-adjusted (adjusting for age, hypertension,
smoking, diabetes, ECG left ventricular hypertrophy, myocardial infarction,
congestive heart failure, and valvular heart disease) hazard ratio (HR) of AF
for death are given below.
Men Women
HR 95%CI HR 95%CI
Age-adjusted 3.7**- 2.9-4.8 4.2*** 3.3-5.4
RF-adjusted 3.1**· 2.3-4.1 2.8**- 2.1-3.7
***p::::: 0.0001
Even when subjects dying within the first 30 days of AF were excluded
from analysis, AF carried a significantly elevated risk for death (RF-adjusted
HR 2.4·" in both sexes).
Conclusion: AF has a negative impact on survival, independent of the pre-
existing cardiovascular conditions with which it is often associated. The in-
creased mortality of AF underscores the importance of its prevention.
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Proven Efficacy of Repeated Dose Intravenous
Ibutilide, a Class III Antiarrhythmic Drug, for Rapid
Termination of Chronic Atrial Flutter or Fibrillation:
Results of a Multicenter Placebo-Controlled Study
Bruce S. Stambler, Arthur S. Portnow, Mark A. Wood, James T. VanderLugt, Linda
K. Wakefield, Kim T. Perry, Gail L. Jungbluth, Kenneth A. Ellenbogen, Ibutilide
Repeat Dose Study Group. McGuire VA Medical Center, Medical College of Virginia,
The Upjohn Company, Richmond, VA and Killamazoo, MI
Currently available antiarrhythmic drugs have limited efficacy for the acute,
rapid, pharmacological termination of chronic atrial fibrillation (AF) or flut-
ter (AFL). The objective of this double-blind, placebo-controlled, randomized,
multicenter study was to determine the efficacy and safety of repeated doses
of intravenous ibutilide in terminating AF and AFL.
Methods: Two hundred forty-two evaluable patients (mean age 66.9 years,
80% male, 75% with heart disease) with sustained AF In = 121) or AFL (n
= 121) (duration 3 hrs to 45 days) were randomized into 3 groups to receive
two 1O-minute infusions separated by 10 minutes: placebo/placebo In = 81);
1 mg/0.5 mg ibutilide (n = 79); 1 mgll mg ibutilide (n = 82). The infusions
were discontinued at the time of arrhythmia termination.
Results: The cumulative conversion efficacy after the two ibutilide infu-
sions was greater (both p < 0.0001) than after placebo (47% vs. 2%). There
was no significant difference in success rates between the two ibutilide
doses (44% vs. 49%). Conversion efficacy of ibutilide was greater for AFL
than AF (63% vs. 31 %). In patients who failed to convert with the first in-
fusion, the success rates after a second infusion were 2%, 27%, and 36%
for placebo, 0.5 mg ibutilide and 1 mg ibutilide. The mean time to arrhyth-
mia termination was 27 minutes after the start of the first infusion. Predic-
tors of arrhythmia termination were arrhythmia duration and left atrial size (in
AF group onlyl. Ejection fraction, valvular disease, concomitant medications,
plasma ibutilide concentration and OTc interval did not predict arrhythmia ter-
mination. Of 180 total ibutilide patients, 3 (1.7%) developed sustained poly-
morphic ventricular tachycardia (pVT.) requiring cardioversion and 12 (6.7%)
